Suppr超能文献

癌症细胞代谢和重编程中的失调转录因子。

Deregulated transcription factors in cancer cell metabolisms and reprogramming.

机构信息

Department of Cancer Biology, Wake Forest Baptist Medical Center, Wake Forest University, Winston-Salem, NC 27101, USA.

Department of Cancer Biology, Wake Forest Baptist Medical Center, Wake Forest University, Winston-Salem, NC 27101, USA.

出版信息

Semin Cancer Biol. 2022 Nov;86(Pt 3):1158-1174. doi: 10.1016/j.semcancer.2022.10.001. Epub 2022 Oct 13.

Abstract

Metabolic reprogramming is an important cancer hallmark that plays a key role in cancer malignancies and therapy resistance. Cancer cells reprogram the metabolic pathways to generate not only energy and building blocks but also produce numerous key signaling metabolites to impact signaling and epigenetic/transcriptional regulation for cancer cell proliferation and survival. A deeper understanding of the mechanisms by which metabolic reprogramming is regulated in cancer may provide potential new strategies for cancer targeting. Recent studies suggest that deregulated transcription factors have been observed in various human cancers and significantly impact metabolism and signaling in cancer. In this review, we highlight the key transcription factors that are involved in metabolic control, dissect the crosstalk between signaling and transcription factors in metabolic reprogramming, and offer therapeutic strategies targeting deregulated transcription factors for cancer treatment.

摘要

代谢重编程是癌症的一个重要标志,在癌症恶性进展和治疗耐药中发挥关键作用。癌细胞重新编程代谢途径,不仅产生能量和构建块,还产生许多关键信号代谢物,影响信号转导和表观遗传/转录调控,促进癌细胞增殖和存活。深入了解代谢重编程在癌症中的调控机制,可能为癌症靶向治疗提供新的策略。最近的研究表明,在各种人类癌症中观察到失调的转录因子,这些转录因子显著影响癌症中的代谢和信号转导。在本综述中,我们重点介绍了参与代谢调控的关键转录因子,剖析了信号转导与代谢重编程中转录因子之间的相互作用,并提出了针对失调转录因子的治疗策略,以用于癌症治疗。

相似文献

1
Deregulated transcription factors in cancer cell metabolisms and reprogramming.
Semin Cancer Biol. 2022 Nov;86(Pt 3):1158-1174. doi: 10.1016/j.semcancer.2022.10.001. Epub 2022 Oct 13.
2
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.
Cancer Commun (Lond). 2022 Nov;42(11):1049-1082. doi: 10.1002/cac2.12374. Epub 2022 Oct 20.
3
Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics.
J Cancer Prev. 2016 Dec;21(4):209-215. doi: 10.15430/JCP.2016.21.4.209. Epub 2016 Dec 30.
4
The role of ubiquitination and deubiquitination in cancer metabolism.
Mol Cancer. 2020 Oct 1;19(1):146. doi: 10.1186/s12943-020-01262-x.
5
Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression.
Cell Mol Life Sci. 2016 Jan;73(2):377-92. doi: 10.1007/s00018-015-2070-4. Epub 2015 Oct 23.
6
Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.
FEBS J. 2022 Mar;289(5):1302-1314. doi: 10.1111/febs.16032. Epub 2021 Jun 11.
7
FoxO transcription factors in cancer metabolism.
Semin Cancer Biol. 2018 Jun;50:65-76. doi: 10.1016/j.semcancer.2018.01.004. Epub 2018 Jan 5.
8
Deregulated transcription factors in the emerging cancer hallmarks.
Semin Cancer Biol. 2024 Jan;98:31-50. doi: 10.1016/j.semcancer.2023.12.001. Epub 2023 Dec 18.
9
Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer.
Int J Mol Sci. 2020 Nov 30;21(23):9125. doi: 10.3390/ijms21239125.
10
N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies.
Cancer Lett. 2022 Sep 28;544:215815. doi: 10.1016/j.canlet.2022.215815. Epub 2022 Jul 5.

引用本文的文献

1
4
Molecular Targets in Alveolar Rhabdomyosarcoma: A Narrative Review of Progress and Pitfalls.
Int J Mol Sci. 2025 May 28;26(11):5204. doi: 10.3390/ijms26115204.
5
Fumarate hydratase in cancer research: scientific trends and findings over 22 years.
Discov Oncol. 2025 May 29;16(1):949. doi: 10.1007/s12672-025-02312-w.

本文引用的文献

1
Inspiratory hyperoxia suppresses lung cancer metastasis through a MYC/SLC1A5-dependent metabolic pathway.
Eur Respir J. 2022 Dec 1;60(6). doi: 10.1183/13993003.00062-2022. Print 2022 Dec.
2
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape.
J Hematol Oncol. 2022 Jun 3;15(1):77. doi: 10.1186/s13045-022-01292-6.
3
Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism.
Front Genet. 2022 Mar 31;13:849040. doi: 10.3389/fgene.2022.849040. eCollection 2022.
4
Bioenergetic and Metabolic Adaptation in Tumor Progression and Metastasis.
Front Oncol. 2022 Mar 17;12:857686. doi: 10.3389/fonc.2022.857686. eCollection 2022.
5
Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions.
BMC Cancer. 2022 Jan 6;22(1):39. doi: 10.1186/s12885-021-09151-2.
6
The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses.
Front Cell Dev Biol. 2021 Nov 18;9:775507. doi: 10.3389/fcell.2021.775507. eCollection 2021.
7
Targeting cancer metabolism in the era of precision oncology.
Nat Rev Drug Discov. 2022 Feb;21(2):141-162. doi: 10.1038/s41573-021-00339-6. Epub 2021 Dec 3.
8
MYC regulates metabolism through vesicular transfer of glycolytic kinases.
Open Biol. 2021 Dec;11(12):210276. doi: 10.1098/rsob.210276. Epub 2021 Dec 1.
10
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer.
Cancer Metab. 2021 Sep 23;9(1):33. doi: 10.1186/s40170-021-00270-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验